Ana içeriğe atla

Kayıtlar

Nitelikli

How Corporate Health Care Leaders Maintain Their Impunity: The Case of Purdue Pharma's Funding of the Washington Legal Foundation to Attempt to Weaken the Responsible Corporate Officer Doctrine

The ongoing epidemic of narcotic (opioid) abuse, and the resulting rise in the deaths due to overdoses, has focused attention on pharmaceutical companies' aggressive promotion of these drugs which minimized their substantial risk. A recent article in the Intercept showed how the leadership of one such company tried to insulate itself from responsibility for such actions even while such promotions were continuing. Background: Impunity of Top Leaders of Big Health Care Organizations For years, we have railed against the impunity of top leaders of health care organizations.  We have noted that despite numerous legal settlements made by health care organizations of alllegations like fraud , bribery , and kickbacks , almost never do top leaders who presided over these actions face any negative consequences.  Lack of deterrence caused by such impunity appears to be a major cause of  the epidemic of continuing unethical behavior, crime and corruption on the part of large health car

Will There Be an Obamacare Death Spiral in 2015? No

Free e-Book and Ideal Weight Program 2.0 Announcement

Does the Vitamin and Mineral Content of Food Influence Our Food Intake and Body Fatness?

HealthCare.gov Enrolls 1.1 Million by Year-End––Cause For Celebration or Worry?

Himalaya tuzu

The Obamacare Slippery Slope––What's Your "Hardship?"

Health Care and Christmas 2013

Food Reward Friday

Health Care and Germs

Obamacare Week 10––A Dearth of Enrollment In the States and Continuing Backroom Problems

Does "Metabolically Healthy Obesity" Exist?